News on Amgen Inc from BioPortfolio.com http://www.BioPortfolio.com Consolidated Amgen Inc news from BioPortfolio.com Wed, 10 Feb 2010 09:48:24 GMT en D-Mab Ascending Bone Throne: Phase III Strong in Prostate, toohttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039485&HITNO=0&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Amgen%20Inc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039485&THISHREF=http://c.moreover.com/click/here.pl%3fz2538147883%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039485&HITNO=0&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Amgen%20Inc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039485&THISHREF=http://c.moreover.com/click/here.pl%3fz2538147883%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comTherapeutics Daily: Amgen Sees Positive Data in Bone Drug Studyhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039885&HITNO=1&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Amgen%20Inc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039885&THISHREF=http://c.moreover.com/click/here.pl%3fz2538447805%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039885&HITNO=1&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Amgen%20Inc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039885&THISHREF=http://c.moreover.com/click/here.pl%3fz2538447805%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmaceuticalProcessing: Neuraltus Pharmaceuticals names new president and CEO - Zibb.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4040164&HITNO=2&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Amgen%20Inc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4040164&THISHREF=http://c.moreover.com/click/here.pl%3fz2538621278%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4040164&HITNO=2&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Amgen%20Inc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4040164&THISHREF=http://c.moreover.com/click/here.pl%3fz2538621278%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comZibb: Neuraltus Pharmaceuticals names new president and CEOhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4040064&HITNO=3&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Amgen%20Inc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4040064&THISHREF=http://c.moreover.com/click/here.pl%3fz2538561718%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4040064&HITNO=3&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Amgen%20Inc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4040064&THISHREF=http://c.moreover.com/click/here.pl%3fz2538561718%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comTradingMarkets: Mansell Promoted to Manager, U.S. Fleet Services for Amgen USAhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039613&HITNO=4&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Amgen%20Inc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039613&THISHREF=http://c.moreover.com/click/here.pl%3fz2538250607%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039613&HITNO=4&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Amgen%20Inc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039613&THISHREF=http://c.moreover.com/click/here.pl%3fz2538250607%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comFleet Financials: Amgen Sees Positive Results from Osteoporosis Drughttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4037435&HITNO=5&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Amgen%20Inc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4037435&THISHREF=http://c.moreover.com/click/here.pl%3fz2537076644%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4037435&HITNO=5&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Amgen%20Inc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4037435&THISHREF=http://c.moreover.com/click/here.pl%3fz2537076644%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comSeeking Alpha: Positive Results on Amgen Drug - Analyst Bloghttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4036419&HITNO=6&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Amgen%20Inc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4036419&THISHREF=http://c.moreover.com/click/here.pl%3fz2536606007%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4036419&HITNO=6&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Amgen%20Inc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4036419&THISHREF=http://c.moreover.com/click/here.pl%3fz2536606007%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comBenzinga.com: Amgen sees positive data in bone drug studyhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4036030&HITNO=7&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Amgen%20Inc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4036030&THISHREF=http://c.moreover.com/click/here.pl%3fz2536473411%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4036030&HITNO=7&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Amgen%20Inc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4036030&THISHREF=http://c.moreover.com/click/here.pl%3fz2536473411%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comYahoo! Canada: Amgen sees positive data in bone drug studyhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4036027&HITNO=8&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Amgen%20Inc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4036027&THISHREF=http://c.moreover.com/click/here.pl%3fz2536471615%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4036027&HITNO=8&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Amgen%20Inc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4036027&THISHREF=http://c.moreover.com/click/here.pl%3fz2536471615%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comYahoo! Canada: UPDATE 1-Amgen: denosumab prostate cancer goal meets goalshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4032266&HITNO=9&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Amgen%20Inc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4032266&THISHREF=http://c.moreover.com/click/here.pl%3fz2534570316%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4032266&HITNO=9&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Amgen%20Inc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4032266&THISHREF=http://c.moreover.com/click/here.pl%3fz2534570316%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comInteractive Investor: Amgen Drug Reduces Bone Breaks in Prostate Patients (Update1)http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4032936&HITNO=10&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Amgen%20Inc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4032936&THISHREF=http://c.moreover.com/click/here.pl%3fz2534900893%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4032936&HITNO=10&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Amgen%20Inc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4032936&THISHREF=http://c.moreover.com/click/here.pl%3fz2534900893%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comBusinessWeek: California Court of Appeal Orders Arbitration, Finding Arbitration Agreement Not Unconscionablehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038206&HITNO=11&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Amgen%20Inc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038206&THISHREF=http://c.moreover.com/click/here.pl%3fz2537528457%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038206&HITNO=11&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Amgen%20Inc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038206&THISHREF=http://c.moreover.com/click/here.pl%3fz2537528457%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comJackson Lewis: UPDATE 2-Amgen: denosumab prostate cancer trial meets goalshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4032437&HITNO=12&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Amgen%20Inc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4032437&THISHREF=http://c.moreover.com/click/here.pl%3fz2534652402%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4032437&HITNO=12&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Amgen%20Inc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4032437&THISHREF=http://c.moreover.com/click/here.pl%3fz2534652402%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comReuters: UPDATE 2-Amgen: denosumab prostate cancer trial meets goalshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4032383&HITNO=13&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Amgen%20Inc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4032383&THISHREF=http://c.moreover.com/click/here.pl%3fz2534636610%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4032383&HITNO=13&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Amgen%20Inc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4032383&THISHREF=http://c.moreover.com/click/here.pl%3fz2534636610%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comInteractive Investor: UPDATE 2-Amgen: denosumab prostate cancer trial meets goalshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4032373&HITNO=14&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Amgen%20Inc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4032373&THISHREF=http://c.moreover.com/click/here.pl%3fz2534632824%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4032373&HITNO=14&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Amgen%20Inc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4032373&THISHREF=http://c.moreover.com/click/here.pl%3fz2534632824%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comFinanzNachrichten.de: